NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for NVEC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
quarterly dividend of $1.00 per share maintained | It pays a steady $1.00 quarterly dividend. | Intact | dividend cut below $1.00 per share quarterly | Dividend per share: $1.00 per share FY2027-Q2; GAAP. Published target: >= $1.00 per share quarterly. Target period is not explicitly aligned with this observation. Oct 21, 20261 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a small-cap company with recent strong financial performance, but the evidence points to mixed execution rather than a steady growth pattern. The long-term thesis is in watch mode: the signal recently turned mildly favorable, while total risk rose and the CEO transition remains unresolved.
The valuation evidence describes NVEC as cheap versus peers, but also indicates a 43% premium versus peers and an expectations gap of -0.36, so the signals are mixed. Fragility is low and the priced-in tag is justified, meaning the evidence does not show a broad stack of weak execution, expensive valuation, and market turbulence already embedded in expectations.
Near term, revenue delivery is uneven: first-half revenue rose 36%, while second-quarter revenue fell 8% after an 81% first-quarter increase. The quarterly dividend has been maintained, but the new CEO’s leadership is still a watch item; near-term miss risk is described as low, though small-company size and peer misses add caution.
A guidance cut at the next call would be a meaningful negative for the thesis. Over the multi-year view, results also hinge on whether revenue growth becomes more consistent and the CEO transition supports execution. Rate cuts and stabilization among major technology peers are potential sector tailwinds, but the sector backdrop is neutral.
The 1-to-3-year view is mixed: peer-relative valuation looks cheap, but uneven quarterly results, elevated risk, and leadership change make execution the key test. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in NVE Corp.'s published investment case. The stated target is net income > 0 and positive free cash flow. |
| Intact |
| net income or free cash flow turns negative next year |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
revenue growth stays above -10% next year | A primary condition in NVE Corp.'s published investment case. The stated target is >= -10% YoY. | Intact | YoY revenue growth falls below -10% next year | Revenue growth: -8.07% FY2027-Q2; GAAP. Published target: >= -10% YoY. Target period is not explicitly aligned with this observation. Oct 21, 2026-8.071382 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
PE ratio remains below peer median of 73 | A supporting condition in NVE Corp.'s published investment case. The stated target is <= 73 PE. | Intact | PE ratio rises above 73 | P/E (TTM): 23.25x As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 202623.2487 ratio · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.